GlassScriptPhysician profile
Anila Khan
NPI 1205896974
$1,097.61
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $50.17 · 2022: $12.86 · 2023: $134 · 2024: $222 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $300.00 | 2019 | |
| Exact Sciences Corporation | $137.48 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $103.74 | 2024-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $96.68 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.12 | 2022-2025 | |
| Pfizer INC. | $66.28 | 2023-2025 | |
| Seqirus USA INC | $51.08 | 2025 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $42.74 | 2020-2024 | Invega Sustenna |
| Cranial Technologies, INC | $33.18 | 2025 | Doc Band |
| Amgen INC. | $32.07 | 2024 | Krystexxa |
| Alnylam Pharmaceuticals INC. | $29.48 | 2025 | Givlaari |
| Indivior INC. | $27.92 | 2023 | Perseris |
| Glaxosmithkline, LLC. | $23.58 | 2020 | |
| Ironwood Pharmaceuticals, INC | $22.38 | 2024 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $19.51 | 2025 | Rexulti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $18.37 | 2025 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anila Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.